Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Anny Camelo Castillo"'
Autor:
Maria Buti, Inês Vaz-Pinto, Vítor Magno Pereira, Marta Casado, Jordi Llaneras, Ana Barreira, Catarina Esteves, Mafalda Guimarães, Ana Gorgulho, Tomás Mourão, Elisa Xavier, Luís Jasmins, Ana Paula Reis, Nancy Faria, Bruno Freitas, Graça Andrade, Anny Camelo-Castillo, Manuel Ángel Rodríguez-Maresca, Alba Carrodeguas, Diogo Medina, Rafael Esteban
Publikováno v:
International Journal of Emergency Medicine, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Background Undiagnosed cases of hepatitis C virus (HCV) infection result in significant morbidity and mortality, further transmission, and increased public health costs. Testing in emergency departments (EDs) is an opportunity to expand HCV
Externí odkaz:
https://doaj.org/article/c6d84caab2d84245b51cbf4e19eef20b
Autor:
Anny Camelo-Castillo, Desirée Henares, Pedro Brotons, Antonio Galiana, Juan Carlos Rodríguez, Alex Mira, Carmen Muñoz-Almagro
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Background and Aims: The risk of suffering from some infectious diseases can be related to specific microbiota profiles. Specifically, the nasopharyngeal microbiota could play a role as a risk or protective factor in the development of invasive disea
Externí odkaz:
https://doaj.org/article/69e713ebab7e48e5b417e82ef9195971
Autor:
Alex Mira, Vicente Esparza-Villalpando, Anny Camelo-Castillo, Arantxa López-López, Hiram D. López-Santacruz, Saray Aranda-Romo, Ainhoa Revilla-Guarinos
Publikováno v:
INTERNATIONAL MICROBIOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Streptococcus dentisani has been proposed as a promising probiotic against tooth decay, due to its ability to buffer acidic pH and to inhibit the growth of oral pathogens. However, it is unknown if this bacterial species has a global distribution. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4475bcf2c5aaa0b2aae3c8549182aef7
https://doi.org/10.1007/s10123-021-00222-9
https://doi.org/10.1007/s10123-021-00222-9
Autor:
Maria Buti, Inês Vaz Pinto, Vítor Magno Pereira, Marta Casado, Jordi Llaneras, Ana Barreira, Catarina Esteves RN, Mafalda Guimarães, Ana Gorgulho, Tomás Mourão, Elisa Xavier, Luís Jasmins, Ana Paula Reis, Nancy Faria, Bruno Freitas, Graça Andrade, Anny Camelo-Castillo, Manuel Ángel Rodríguez-Maresca, Alba Carrodeguas, Diogo Medina, Rafael Esteban
Background: Undiagnosed cases of transmissible blood-borne viruses (HCV and HIV) result in significant morbidity and mortality, further spread of epidemics, and increased public health costs. Testing in emergency departments (EDs) is an opportunity f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4dd0fdaf76a17aae46dfd28c0269341
https://doi.org/10.21203/rs.3.rs-2237854/v1
https://doi.org/10.21203/rs.3.rs-2237854/v1
Autor:
Anny Camelo-Castillo, José Miguel Rivera-Caravaca, Francisco Marín, Cecilia López-García, Esteban Orenes-Piñero, Inmaculada Ramírez-Macías
Publikováno v:
Critical Reviews in Food Science and Nutrition. 62:3738-3750
Atherosclerosis is a chronic, progressive, inflammatory disease in the vasculature and is common in both coronary and peripheral arteries. Human beings harbor a complex and dynamic population of microorganisms defined as the microbiota. Importantly,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347589af64359a3413d47f4a59aa9822
https://doi.org/10.1080/10408398.2020.1868397
https://doi.org/10.1080/10408398.2020.1868397
Autor:
María Asunción Esteve-Pastor, Francisco Marín, Vanessa Roldán, Gregory Y.H. Lip, Inmaculada Ramírez-Macías, José Miguel Rivera-Caravaca, Anny Camelo-Castillo
Publikováno v:
Expert Opinion on Pharmacotherapy
Rivera-Caravaca, J M, Esteve-Pastor, M A, Camelo-Castillo, A, Ramírez-Macías, I, Lip, G Y H, Roldán, V & Marín, F 2020, ' Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage : an overview of the pharmacotherapy ', Expert Opinion on Pharmacotherapy, vol. 21, no. 15, pp. 1867-1881 . https://doi.org/10.1080/14656566.2020.1789099
Rivera-Caravaca, J M, Esteve-Pastor, M A, Camelo-Castillo, A, Ramírez-Macías, I, Lip, G Y H, Roldán, V & Marín, F 2020, ' Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage : an overview of the pharmacotherapy ', Expert Opinion on Pharmacotherapy, vol. 21, no. 15, pp. 1867-1881 . https://doi.org/10.1080/14656566.2020.1789099
Introduction: Oral anticoagulants (OAC) reduce stroke/systemic embolism and mortality risks in atrial fibrillation (AF). However, there is an inherent bleeding risk with OAC, where intracranial hemorrhage (ICH) is the most feared, disabling, and leth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e4ee982a9f42b7a2eb6cd1e956a02a
https://doi.org/10.1080/14656566.2020.1789099
https://doi.org/10.1080/14656566.2020.1789099
Autor:
Anny Camelo Castillo, Marta Casado, Teresa Cabezas Fernandez, Pedro Amado Villanueva, Alba Carrodeguas, Diogo Medina, José Luis Vega Sáenz, Manuel Rodriguez Maresca
Publikováno v:
Journal of Hepatology. 77:S577-S578
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfaa86b2323fb7d637e6b6b236cc1e19
https://doi.org/10.1016/s0168-8278(22)01476-3
https://doi.org/10.1016/s0168-8278(22)01476-3
Autor:
María Asunción Esteve-Pastor, Antonio Tello-Montoliu, Francisco Marín, Pablo Gil-Pérez, Esteban Orenes-Piñero, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Cecilia López-García, José Miguel Rivera-Caravaca
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7113, p 7113 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Peripheral artery disease (PAD) is a major cause of morbidity and mortality but it is usually underdiagnosed and undertreated. Patients with PAD present dysregulated procoagulant, anticoagulant, and fibrinolytic pathways leading to arterial and venou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658b9f910e7603e7bd43f5de70771be3
https://www.mdpi.com/1422-0067/22/13/7113
https://www.mdpi.com/1422-0067/22/13/7113
Autor:
Inmaculada Ramírez-Macías, Esteban Orenes-Piñero, Anny Camelo-Castillo, Francisco Marín, Gregory Y.H. Lip, Vanessa Roldán, José Miguel Rivera-Caravaca
Publikováno v:
Journal of Clinical Medicine
Camelo-Castillo, A, Rivera-Caravaca, J M, Orenes-Piñero, E, Ramírez-Macías, I, Roldán, V, Lip, G Y H & Marín, F 2021, ' Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users : A Review of Potential Implications ', Journal of Clinical Medicine, vol. 10, no. 4, 715, pp. 1-16 . https://doi.org/10.3390/jcm10040715
Journal of Clinical Medicine, Vol 10, Iss 715, p 715 (2021)
Camelo-Castillo, A, Rivera-Caravaca, J M, Orenes-Piñero, E, Ramírez-Macías, I, Roldán, V, Lip, G Y H & Marín, F 2021, ' Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users : A Review of Potential Implications ', Journal of Clinical Medicine, vol. 10, no. 4, 715, pp. 1-16 . https://doi.org/10.3390/jcm10040715
Journal of Clinical Medicine, Vol 10, Iss 715, p 715 (2021)
The efficacy and safety of vitamin K antagonists (VKAs) as oral anticoagulants (OACs) depend on the quality of anticoagulation control, as reflected by the mean time in therapeutic range (TTR). Several factors may be involved in poor TTR such as como
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ca5b215305bfe94c125c7ea31bde80
http://europepmc.org/articles/PMC7916955
http://europepmc.org/articles/PMC7916955
Autor:
Anny Camelo-Castillo, Vicente Vicente, Francisco Marín, Vanessa Roldán, Gregory Y.H. Lip, José Miguel Rivera-Caravaca
Publikováno v:
THROMBOSIS AND HAEMOSTASIS
Camelo-Castillo, A, Rivera-Caravaca, J M, Marín, F, Vicente, V, Lip, G Y H & Roldán, V 2020, ' Predicting adverse events beyond stroke and bleeding with the ABC-stroke and ABC-bleeding scores in patients with atrial fibrillation : The Murcia AF project ', Thrombosis and Haemostasis, vol. 120, no. 8, pp. 1200-1207 . https://doi.org/10.1055/s-0040-1712914
Camelo-Castillo, A, Rivera-Caravaca, J M, Marín, F, Vicente, V, Lip, G Y H & Roldán, V 2020, ' Predicting adverse events beyond stroke and bleeding with the ABC-stroke and ABC-bleeding scores in patients with atrial fibrillation : The Murcia AF project ', Thrombosis and Haemostasis, vol. 120, no. 8, pp. 1200-1207 . https://doi.org/10.1055/s-0040-1712914
Background The ABC (age, biomarkers, and clinical history)-stroke and ABC-bleeding are biomarker-based scores proposed to predict stroke and bleeding, but non-specificity of biomarkers is common, predicting different clinical events at the same time.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33bb900944d690887b7b405ea30bae5
https://pubmed.ncbi.nlm.nih.gov/32506417
https://pubmed.ncbi.nlm.nih.gov/32506417